Creative Medical Technology Holdings (CELZ) Non Operating Income (2010 - 2026)
Creative Medical Technology Holdings' (CELZ) quarterly Non Operating Income came in at $50913.0 in Q2 2026, up 68.49% year-over-year from $30217.0 in Q2 2025, and down 8.16% quarter-over-quarter from $55436.0 in Q1 2026.
Powered by 
Analysis
Creative Medical Technology Holdings (CELZ) Non Operating Income (2010 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Non Operating Income for 14 consecutive years, with $50913.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non Operating Income rose 68.49% year-over-year to $50913.0 in Q2 2026; TTM through Jun 2026 was $201557.0, a 31.05% increase from a year earlier, with the FY2025 full-year figure at $147806.0, down 40.97% from the prior year.
- Non Operating Income was $50913.0 for Q2 2026 at Creative Medical Technology Holdings, down from $55436.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $93265.0 in Q4 2023 and troughed at $22381.0 in Q1 2025.
- A 5-year average of $58651.3 and a median of $59627.5 in 2023 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income sank 72.57% in 2025 and jumped 147.69% in 2026, its largest moves.
- Over 5 years, Non Operating Income stood at $62245.0 in 2022, then surged by 49.84% to $93265.0 in 2023, then slumped by 66.05% to $31660.0 in 2024, then jumped by 83.54% to $58108.0 in 2025, then retreated by 12.38% to $50913.0 in 2026.
- The last three Non Operating Income figures came in at $50913.0 (Q2 2026), $55436.0 (Q1 2026), and $58108.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 27.08 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 3.88 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | -2.57 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -15.04 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 1.77 Mn |
| 10 | Creative Medical Technology Holdings | 1.48 Mn | 1.50 Mn | - | 50,913.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50,913.00 |
| Mar 31, 2026 | 55,436.00 |
| Dec 31, 2025 | 58,108.00 |
| Sep 30, 2025 | 37,100.00 |
| Jun 30, 2025 | 30,217.00 |
| Mar 31, 2025 | 22,381.00 |
| Dec 31, 2024 | 31,660.00 |
| Sep 30, 2024 | 69,539.00 |
| Jun 30, 2024 | 67,578.00 |
| Mar 31, 2024 | 81,603.00 |
| Dec 31, 2023 | 93,265.00 |
| Sep 30, 2023 | 89,233.00 |
| Jun 30, 2023 | 89,913.00 |
| Mar 31, 2023 | 61,147.00 |
| Dec 31, 2022 | 62,245.00 |
| Sep 30, 2022 | 38,083.00 |
| Dec 31, 2021 | -2.40 Mn |
| Sep 30, 2021 | -1.01 Mn |
| Jun 30, 2021 | -2.39 Mn |
| Mar 31, 2021 | 28.14 Mn |